Atlas Trials

TEMPORARILY_NOT_AVAILABLE

35 clinical trials · Status

Sort:Newest firstOldest first

◉ Watch TEMPORARILY_NOT_AVAILABLE

RecordFirmDate
Autologous Platelet-rich Plasma (aPRP) for Complex Aortic Arch Surgerymacrovascular Operation (NCT02572440)Beijing Anzhen Hospital2014-10-01
Oral Health Promotion and Anti-inflammatory Effects of Fermented Lingonberry Juice Gel. (NCT07737574)Hanna Lahteenmaki
Expanded Access Protocol for Gene Therapy Utilizing shmiR Lentivirus Vector to Induce Fetal Hemoglobin in Sickle Cell Disease (NCT07640815)David Williams
Expanded Access to Telisotuzumab Vedotin (NCT04830202)AbbVie
Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors (NCT05389514)Providence Health & Services
Development of a Fall Prevention and Fall Detection System for Ambulatory Rehabilitation of Parkinson's Patients (NCT01262950)Far Eastern Memorial Hospital
Expanded Access Program Evaluating SkinTE in the Treatment of Wagner 1 Diabetic Foot Ulcers (NCT07222540)PolarityTE
Open-label Evaluation of Polymyxin B Hemoperfusion for Septic Shock (NCT02825329)Spectral Diagnostics (US) Inc.
Treating Amyotrophic Lateral Sclerosis (ALS) With R(+) Pramipexole Dihydrochloride Monohydrate at 60 mg/Day (NCT00596115)Bennett, James P., Jr., M.D., Ph.D.
Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA) (NCT05221619)Janssen Research & Development, LLC
Individual Patient Expanded Access to CA102N (NCT05274204)Holy Stone Healthcare Co., Ltd
Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT06033001)Lantheus Medical Imaging
Treatment (Compassionate) Use of Device - PK Papyrus (NCT05436470)University of Miami
RAPA-501 Therapy of ALS Expanded Access Protocol (NCT06169176)Rapa Therapeutics LLC
Complete Lesion Versus Culprit Lesion Revascularization (NCT01180218)Korea University Guro Hospital
An Expanded Access Program of Garetosmab in Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP) (NCT07301450)Regeneron Pharmaceuticals
Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous Treatments (NCT07517315)Sun Pharma Advanced Research Company Limited
Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA) (NCT07319910)NovoCure GmbH
A Trial of Transcranial Magnetic Stimulation in the Treatment of Functional Dyspepsia (NCT06559748)Second Affiliated Hospital, Zhejiang University, School of Medicine
Expanded Access of Vigil in Solid Tumors (NCT03842865)Gradalis, Inc.
Expanded Access Program for Autologous Muscle Derived Cells (AMDCs) (NCT04661293)Cook MyoSite
Comparison of Clinical and Radiological Results of Using Only Screws and Plate Use in Latarjet Operation in Shoulder Instability (NCT05370742)Istanbul University
Intermediate Expanded Access Protocol CNMAu8.EAP04 (NCT06408727)Clene Nanomedicine
Ampligen in Chronic Fatigue Syndrome (NCT00215813)AIM ImmunoTech Inc.
Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy (NCT01297101)Shanghai Chest Hospital
Intermediate Expanded Access Protocol CNMAu8.EAP03 (NCT04081714)Clene Nanomedicine
Expanded Access to RGX-202 (NCT07652606)REGENXBIO Inc.
A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects. (NCT01889745)Biotoxtech Co., Ltd
Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular Disease and Dialysis Access (NCT07141641)Humacyte, Inc.
INTERMEDIATE-SIZE PATIENT POPULATIONS EXPANDED ACCESS TO TREATMENT FOR SARCOPENIC OBESITY (NCT06784297)Immunis, Inc.
Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer (NCT02011880)Shanghai University of Traditional Chinese Medicine
Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty (NCT06383611)Osteal Therapeutics, Inc.

Track TEMPORARILY_NOT_AVAILABLE automatically

Every clearance here is in the API, with alerts when new ones post.